Neoplasms, Unknown Primary - 24 Studies Found Completed : Gemox as First and Second Line Therapy in Unknown Primary Cancer : Unknown Primary Neoplasms : 2006-07-13 : Drug: Gemcitabine (Gemox) 1000 Completed : Review of Molecular Profiling-Real Time Polymerase Chain Reaction (Rt-Pcr) in Unknown Primary Cancer : Unknown Primary Cancer : 2009-04-03 Completed : Cost-effectiveness Study of miRview™ Mets in Patients With Cancer of Unknown Primary (CUP) : Neoplasms, Unknown Primary : 2010-09-14 Completed : Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Carcinoma of Unknown Primary Site : Neoplasm, Unknown Primary : 2006-08-02 : Drug: paclitaxel Paclitaxel 17 Completed : Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site : Neoplasms, Unknown Primary : 2005-09-12 : Drug: Oxaliplatin 130 mg/m2 IV Completed : Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site : Neoplasms, Unknown Primary : 2005-09-12 : Drug: Etoposide 50 mg alternat Completed : Trial Comparing a Strategy Based on Molecular Analysis to the Empiric Strategy in Patients With CUP : Neoplasms, Unknown Primary : 2012-02-13 : Other: Cancer Type ID test Completed : Bevacizumab and Erlotinib in the Treatment of Patients With Carcinoma of Unknown Primary Site : Neoplasms, Unknown Primary : 2005-09-12 : Drug: Bevacizumab Drug: Erlotinib Completed : Paclitaxel/Carboplatin With or Without Cetuximab in CUP : Neoplasms, Unknown Primary Carcinoma : 2009-05-06 : Drug: paclitaxel/carboplatin 6 Completed : Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin : Carcinoma of Unknown Primary : 1999-11-01 : Drug: carboplatin Drug: etoposide Next >>>
